methyldopa has been researched along with isocarboxazid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bush, CM | 1 |
| De la Parra, DA; van Miert, AS | 1 |
| Benati, E; Colombo, G; Tolva, D | 1 |
| CAHEN, RL | 1 |
1 review(s) available for methyldopa and isocarboxazid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for methyldopa and isocarboxazid
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Pituitary-adrenal axis activation as a function of hypothalamic 5-hydroxytryptamine titre.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Ascorbic Acid; Decarboxylation; Female; Hypothalamus; Isocarboxazid; Methyldopa; Monoamine Oxidase Inhibitors; Pituitary Gland; Pituitary-Adrenal System; Rats; Reserpine; Serotonin; Stimulation, Chemical; Time Factors | 1971 |
Inhibition of gastric emptying by endotoxin (bacterial lipopolysaccharide) in conscious rats and modification of this response by drugs affecting the autonomic nervous system.
Topics: Adrenalectomy; Aminocaproates; Animals; Autonomic Agents; Carbachol; Dibenzylchlorethamine; Endotoxins; Ethanolamines; Gastrointestinal Motility; Insulin; Isocarboxazid; Lipopolysaccharides; Methods; Methyldopa; Phentolamine; Polysaccharides, Bacterial; Propranolol; Rats; Reserpine; Stomach; Sympatholytics | 1970 |
[Isocarboxazide as an antagonist of the hypotensive effect of alpha-methyldopa].
Topics: Aged; Female; Humans; Hypertension; Isocarboxazid; Male; Methyldopa; Middle Aged | 1966 |
ON THE MECHANISM OF EMESIS INDUCED BY 5-HYDROXYTRYPTAMINE.
Topics: Brain Chemistry; Cats; Chlorpromazine; Iproniazid; Isocarboxazid; Methyldopa; Monoamine Oxidase Inhibitors; Nialamide; Pentobarbital; Pharmacology; Research; Reserpine; Serotonin; Toxicology; Tyrosine; Vomiting | 1964 |